SCOPUS 정보 검색 플랫폼

BJU International

Volumn 112, Issue 3, 2013, Pages 404-406

Tools to investigate biomarker expression in bladder cancer progression

(1) Galustian, Christine a

a GUY S HOSPITAL (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; ALPHA2 GLYCOPROTEIN; APOLIPOPROTEIN E; DNA DIRECTED DNA POLYMERASE BETA; DNA TOPOISOMERASE (ATP HYDROLYSING) A; TUMOR MARKER;

ARTICLE; BLADDER CANCER; CANCER GROWTH; CANCER TISSUE; DISEASE SEVERITY; HUMAN; IMMUNOHISTOCHEMISTRY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN URINE LEVEL; PROTEOMICS; TISSUE MICROARRAY; TUMOR BIOPSY; WESTERN BLOTTING;

BIOLOGICAL MARKERS; DISEASE PROGRESSION; HUMANS; URINARY BLADDER NEOPLASMS;

EID: 84879852130 PISSN: 14644096 EISSN: 1464410X Source Type: Journal
DOI: 10.1111/j.1464-410X.2013.11792.x Document Type: Article

Times cited : (3)

References (13)

1
- 84879879480
- Tumour expression of bladder cancer-associated urinary proteins
- et al.
- Lindén M, Segersten U, Runeson M, et al. Tumour expression of bladder cancer-associated urinary proteins. BJU Int 2013; 112: 407-415
- (2013) BJU Int , vol.112 , pp. 407-415
- Lindén, M.¹ Segersten, U.² Runeson, M.³

2
- 33845205234
- Advances in Cancer Research. Academic Press
- Lee JW, Figeys D, Vasilescu J, et al. Biomarker Assay Translation from Discovery to Clinical Studies in Cancer Drug Development: Quantification of Emerging Protein Biomarkers. In:Vol. Volume 96. Advances in Cancer Research. Academic Press: 2006; 269-298
- (2006) Biomarker Assay Translation from Discovery to Clinical Studies in Cancer Drug Development: Quantification of Emerging Protein Biomarkers , vol.96 , pp. 269-298
- Lee, J.W.¹ Figeys, D.² Vasilescu, J.³

3
- 78649980497
- Lipidomics: New tools and applications
- Wenk MR,. Lipidomics: new tools and applications. Cell 2010; 143: 888-895
- (2010) Cell , vol.143 , pp. 888-895
- Wenk, M.R.¹

4
- 79251489778
- Glycomics Hits the Big Time
- Hart GW, Copeland RJ,. Glycomics Hits the Big Time. Cell 2010; 143: 672-676
- (2010) Cell , vol.143 , pp. 672-676
- Hart, G.W.¹ Copeland, R.J.²

5
- 84855469528
- Proteomic analysis of urinary biomarker candidates for nonmuscle invasive bladder cancer
- et al.
- Lindén M, Lind SB, Mayrhofer C, et al. Proteomic analysis of urinary biomarker candidates for nonmuscle invasive bladder cancer. Proteomics 2012; 12: 135-144
- (2012) Proteomics , vol.12 , pp. 135-144
- Lindén, M.¹ Lind, S.B.² Mayrhofer, C.³

6
- 29244477844
- A human protein atlas for normal and cancer tissues based on antibody proteomics
- et al.
- Uhlén M, Björling E, Agaton C, et al. A human protein atlas for normal and cancer tissues based on antibody proteomics. Mol Cell Proteomics 2005; 4: 1920-1932
- (2005) Mol Cell Proteomics , vol.4 , pp. 1920-1932
- Uhlén, M.¹ Björling, E.² Agaton, C.³

7
- 33745026494
- Lipid metabolism, atherogenesis and CD1-restricted antigen presentation
- Major AS, Joyce S, Van Kaer L,. Lipid metabolism, atherogenesis and CD1-restricted antigen presentation. Trends Mol Med 2006; 12: 270-278
- (2006) Trends Mol Med , vol.12 , pp. 270-278
- Major, A.S.¹ Joyce, S.² Van Kaer, L.³

8
- 70349448333
- Efficacy of Bacille Calmette-Guérin immunotherapy predicted by expression of antigen-presenting molecules and chemokines
- et al.
- Videira PA, Calais FM, Correia M, et al. Efficacy of Bacille Calmette-Guérin immunotherapy predicted by expression of antigen-presenting molecules and chemokines. Urology 2009; 74: 944-950
- (2009) Urology , vol.74 , pp. 944-950
- Videira, P.A.¹ Calais, F.M.² Correia, M.³

9
- 34248658381
- α-1-antitrypsin Inhibits caspase-3 activity, preventing lung endothelial cell apoptosis
- et al.
- Petrache I, Fijalkowska I, Medler TR, et al. α-1-antitrypsin Inhibits caspase-3 activity, preventing lung endothelial cell apoptosis. Am J Pathol 2006; 169: 1155-1166
- (2006) Am J Pathol , vol.169 , pp. 1155-1166
- Petrache, I.¹ Fijalkowska, I.² Medler, T.R.³

10
- 0141993055
- Plasminogen supports tumor growth through a fibrinogen-dependent mechanism linked to vascular patency
- et al.
- Palumbo JS, Talmage KE, Liu H, et al. Plasminogen supports tumor growth through a fibrinogen-dependent mechanism linked to vascular patency. Blood 2003; 102: 2819-2827
- (2003) Blood , vol.102 , pp. 2819-2827
- Palumbo, J.S.¹ Talmage, K.E.² Liu, H.³

11
- 37549035033
- Fibrinogen synthesized by cancer cells augments the proliferative effect of fibroblast growth factor-2 (FGF-2)
- et al.
- Sahni A, Simpson-Haidaris PJ, Sahni SK, et al. Fibrinogen synthesized by cancer cells augments the proliferative effect of fibroblast growth factor-2 (FGF-2). J Thromb Haemost 2008; 6: 176-183
- (2008) J Thromb Haemost , vol.6 , pp. 176-183
- Sahni, A.¹ Simpson-Haidaris, P.J.² Sahni, S.K.³

12
- 77949495196
- The RNA polymerase i transcription machinery: An emerging target for the treatment of cancer
- Drygin D, Rice WG, Grummt I,. The RNA polymerase I transcription machinery: an emerging target for the treatment of cancer. Ann Rev Pharmacol Toxicol 2010; 50: 131-156
- (2010) Ann Rev Pharmacol Toxicol , vol.50 , pp. 131-156
- Drygin, D.¹ Rice, W.G.² Grummt, I.³

13
- 84860473453
- MiRNA-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical TGF-β signalling pathway
- et al.
- Lynch J, Fay J, Meehan M, et al. MiRNA-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical TGF-β signalling pathway. Carcinogenesis 2012; 33: 976-985
- (2012) Carcinogenesis , vol.33 , pp. 976-985
- Lynch, J.¹ Fay, J.² Meehan, M.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.